Skip to content

BD BBL™ Acridine Orange Stain 212537Recalls & reported problems

Becton, Dickinson And Company · BD BBL™ Acridine Orange Stain, 4 x 250 mL · Class 1

Data updated Oct 18, 2026 from official FDA records · Editorial policy

Adverse event reports
1
Deaths reported
0
Injuries reported
0
Recalls naming it
0

Summary

The FDA's MAUDE database contains 1 adverse event report that list this exact device (DI 30382902125373), received between Feb 24, 2023 and Feb 24, 2023 — classified as 1 malfunction.

The most frequently reported specific device problem is “Incorrect, Inadequate or Imprecise Result or Readings” (1 report).

Reports come from manufacturers, hospitals and patients and are not verified by the FDA. A report does not prove the device caused the event, and counts can't be used to compare devices or estimate failure rates. What reports can and can't tell you · How this data works · Data updated Oct 18, 2026.

Most reported problems

Device problems

  • Incorrect, Inadequate or Imprecise Result or Readings1

Patient problems

  • No Clinical Signs, Symptoms or Conditions1

Recent adverse event reports

The 1 most recent of 1 reports, in the reporter's own words as published by the FDA.

  • MalfunctionFeb 24, 2023Incorrect, Inadequate or Imprecise Result or Readings; Incorrect, Inadequate or Imprecise Result or Readings

    IT WAS REPORTED WHEN USING BD BBL¿ ACRIDINE ORANGE STAIN HAS PERFORMANCE ISSUES. THE FOLLOWING INFORMATION WAS PROVIDE THE INTIAL REPORTER: RAPID TEST FOR PRESENCE OF MICROORGANISMS (BACTERIA, YEAST, MOLD) LIMITATIONS OF METHOD MULTIPLE STUDIES MENTIONED ACRIDINE ORANGE¿S INABILITY TO DISCRIMINATE BETWEEN A LIVE AND DEAD CELL. SAW POOR CORRELATION BETWEEN THIS METHOD AND INGREDIENTS WHERE THERE WAS A HIGH LEVEL OF NON-VIABLE BACTERIA DUE TO A PROCESS STEP (E.G. BLANCHING OF VEGETABLES).

    Patient problems: No Clinical Signs, Symptoms or Conditions

    MAUDE report 16434405 ↗

Sources and updates

How reports and recalls are matched · Editorial policy · Report an error on this page